Medicine Overview of Glitaris Tablet
Uses of Glitaris Tablet
Glitaris 15mg Tablet is used in the treatment of type 2 diabetes.
Side effects of Glitaris Tablet
Blurred vision, Respiratory tract infection, Bone fracture, Numbness.
How to use Glitaris Tablet
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. It can be taken with or without food, but it is better to take Glitaris 15mg Tablet at a fixed time.
How Glitaris Tablet works
Glitaris 15mg tablet is an anti-diabetic medicine. It works by increasing the body's sensitivity to insulin, a natural substance that helps control blood sugar levels.
In Depth Information on Glitaris Tablet
Expert advice for Glitaris Tablet
- Highly effective in decreasing haemoglobin A1c level (Hemoglobin A1c measures average blood sugar over time).
- Glitaris may rarely cause hypoglycemia.
- Glitaris is more likely to cause weight gain as compared to other anti-diabetic medicines.
- Glitaris may cause fluid retention (edema), ranging from mild ankle swelling to severe swelling in the lungs that make it hard to breathe.
- Inform your doctor if you have ever been diagnosed with any heart problems (high blood pressure, heart attack, heart failure, slow or irregular heart rate).
- Inform your doctor if you have ever been diagnosed with kidney or liver problems.
- Inform your doctor if you have ever been diagnosed with bladder cancer.
Special precautions for Glitaris 15mg Tablet
Taking pioglitazone with alcohol may affect blood glucose levels in patients with diabetes.
WEIGH RISKS VS BENEFITS
Glitaris 15mg Tablet may be unsafe to use during pregnancy.+more
Animal studies have shown adverse effects on the foetus, however, there are limited human studies. The benefits from use in pregnant women may be acceptable despite the risk. Please consult your doctor....
Animal studies have shown adverse effects on the foetus, however, there are limited human studies. The benefits from use in pregnant women may be acceptable despite the risk. Please consult your doctor.
Glitaris 15mg Tablet is probably safe to use during lactation. Limited human data suggests that the drug does not represent a significant risk to the baby.+more
Monitor the breastfed baby’s blood sugar during treatment with Glitaris 15mg Tablet...
Monitor the breastfed baby’s blood sugar during treatment with Glitaris 15mg Tablet
Glitaris 15mg Tablet does not usually affect your ability to drive.
Glitaris 15mg Tablet is safe to use in patients with kidney disease. No dose adjustment of Glitaris 15mg Tablet is recommended.+more
Use of Glitaris 15mg Tablet is not recommended in patients undergoing dialysis....
Use of Glitaris 15mg Tablet is not recommended in patients undergoing dialysis.
Glitaris 15mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Glitaris 15mg Tablet may be needed. Please consult your doctor.+more
Use of Glitaris 15mg Tablet is not recommended in patients with severe liver disease....
Use of Glitaris 15mg Tablet is not recommended in patients with severe liver disease.
Severely interacts with other drugs like
Apidra 100IU Cartridge 3ml, Decamycin 4mg Injection, Walacort 0.5mg Tablet, Pericort 4mg Tablet
If you miss a dose of Pioglitazone, skip it and continue with your normal schedule. Do not double the dose.
Frequently asked questions for Glitaris 15mg Tablet
Frequently asked questions for Pioglitazone
No. Glitaris is an anti-diabetic medication. Blood thinners are the medicine that prevents the formation of a harmful blood clot. These include medicines like Aspirin, Heparin and Warfarin.
Q. Is Glitaris a diuretic?
No. Glitaris is not a diuretic. It is used in the treatment of Diabetes Mellitus. Diuretics are those medicine which increases urination.
Q. Can Glitaris used in Hepatitis B infection?
Some studies have shown that Glitaris may be helpful in preventing Hepatitis B Virus-associated Hepatocellular Cancer (Liver Cancer). However, these findings are still very preliminary and clear role has not been established.
Glitaris has been shown to inhibit Liver Cancer (HCC) recurrence in overweight Hepatitis C Virus-infected diabetic patients. It also improved insulin resistance (a state where the body is resistant to the effects and functions of the insulin hormone) in them.
Q. Can Glitaris used along with Vitamin D?
Studies indicate that Vitamin-D combined with Glitaris may be more effective in improving Bone Mineral Density and Bone Metabolism than Vitamin-D or Glitaris alone in the treatment of Diabetes Mellitus patients with kidney dysfunction (Diabetic Nephropathy).
Q. Can Glitaris be used along with sitagliptin?
Combination therapy with Sitagliptin and Glitaris leads to a substantial and sustained improvement in glycemic (blood sugar) control compared to the treatment with Glitaris alone. This is useful for patients who cannot tolerate Metformin or Sulfonylureas.
Recent evidence suggests that Glitaris may be beneficial in Alzheimer's disease (AD), decreasing the cognitive decline early in the disease process. However, larger studies are now in progress to establish the same.
Q. Can Glitaris and repaglinide combined in diabetes treatment?
For patients who previously failed oral antidiabetic therapy, the combination of Repaglinide and Glitaris have acceptable safety, with greater reductions of glycemic parameters (blood sugar levels) than using either agent alone.
Large population studies indicate that Glitaris is associated with an increased risk of bladder cancer. The absence of an association of bladder cancer with the other drug of the same class, Rosiglitazone, suggests that the increased risk is drug specific and not a class effect.
Q. Are Glitaris and rosiglitazone same?
Glitaris & Rosiglitazone both belong to a class of antidiabetics called Thiazolidinediones. Rosiglitazone has been removed from the market because using this drug was associated with increased risk of cardiovascular events like heart attack and stroke. This is not seen with Glitaris.
Q. Can Glitaris be used along with glimepiride in diabetes?
Glitaris when added to Glimepiride in Patients with Diabetes Mellitus, has been found to significantly reduce plasma lipid levels and significant improvement in blood pressure control related to a reduction in the insulin resistance.
No. Glitaris is not a steroid. It is an anti-diabetic medication which belongs to the class of thiazolidinediones.
Glitaris is an anti-diabetes drug used along with a proper diet and exercise program to control high blood sugar in patients with type 2 diabetes. Glitaris acts as an insulin sensitizer and decreases the extent of insulin resistance in the body too.
Glitaris cardiovascular safety profile compares favourably with that of Rosiglitazone. Glitaris has been found to be associated with bladder tumours but causality assessment has not been proved yet.
Glitaris increases the permeability of fluid in tiny blood vessels called capillaries. This results in easier movement of fluids across the membrane and their consequent accumulation, resulting in oedema (puffiness). Also, Glitaris causes increased sodium and water reabsorption from the kidney that contributes to the oedema.
The mechanism behind the link between Glitaris use and bladder cancer is still unknown. Studies have suggested that use of Glitaris for more than one year results in increased risk of development of tumour of the urinary bladder.
Glitaris can cause fluid retention and edema. Consequently, there is a lot of fluid in the body (fluid overload). As a result, it may precipitate heart failure (which worsens with fluid overload in those at risk).
Studies in animals have concluded that Glitaris improves the elasticity of the aortic wall ( the aorta is a large blood vessel that arises from the heart and supplies oxygenated blood to the rest of the body). This may be a mechanism by which it protects against atherosclerosis, but more studies are needed to confirm this.
The addition of Glitaris reduces daily insulin dosages, but study findings have not been consistent. Improvement of lipid profiles has also been weak with this combination therapy. Long-term studies are needed before any conclusions can be reached. Combination therapy should be primarily used for patients who achieve an insufficient reduction in blood sugar with insulin alone.
Q. Which is not safe in heart failure, Glitaris or rosiglitazone?
Glitaris & Rosiglitazone both belong to a class of antidiabetics called Thiazolidinediones. Rosiglitazone has been removed from the market because using this drug was associated with increased risk of cardiovascular events like heart attack and stroke. Glitaris can cause heart failure too, but the risk is less that that with Rosiglitazone. Both the medicines should be avoided in heart failure.
Fortunately, there are many alternatives to Glitaris- Metformin, Acarbose, Sitagliptin, Exenatide, Insulin or combination therapies of these medicines can be used.
Findings indicate that Glitaris treatment is associated with a reduced dementia risk in Diabetes mellitus patients. Prospective studies are needed to evaluate a possible neuroprotective effect in these patients in an ageing population.
Glitaris may be of use in infertile patients with polycystic ovary syndrome (PCOS) who are resistant to conventional ovulation induction such as by drugs like Clomiphene, Dexamethasone, or Metformin.
The use of Glitaris for plaque psoriasis treatment is controversial. Some studies revealed no effect of Glitaris 30 mg daily neither on the clinical response of moderate-to-severe psoriasis whereas others demonstrate that it could be considered as an efficacious and safe agent for the treatment of plaque psoriasis.
In a research study in a small number of autistic children, daily treatment with 30 or 60 mg Glitaris for 3–4 months induced apparent clinical improvement. Glitaris should be considered for further testing of therapeutic potential in autistic patients but as of now, autism is not an approved indication for Glitaris use.
Glitaris, either alone or as add-on therapy to conventional treatments, could clinically benefit patients of major depression according to a study.
A recent study shows that although Glitaris causes a significant decrease in blood sugar, HbA1C and lipid levels, it is associated with weight gain, which would limit its utility. It has not been shown to cause weight loss.
Glitaris has also been used to treat non-alcoholic steatohepatitis (fatty liver), but this use is presently considered experimental.
Glitaris reduces recurrent stroke and major vascular events in stroke patients with insulin resistance, prediabetes, and diabetes mellitus. However, its use as a preventive therapy requires more research.
User Submitted Feedback For Glitaris 15mg Tablet
Patients taking Glitaris 15mg Tablet
Once A Day
Thrice A Day
Twice A Day
What were the side-effects while using this medicine?
Respiratory tract infection
How do you take this medicine?
With or without food
How much was the improvement?
Please rate this medicine on price?
What are you using this medicine for?
Type 2 diabetes